Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News PerkinElmer ‘to purchase Viacell’

PerkinElmer ‘to purchase Viacell’

5th October 2007

PerkinElmer has announced the signing of a contract whereby the company will purchase Viacell.

Under the terms of the agreement, PerkinElmer states that it will commence a tender to buy all outstanding shares of the biotechnology company for an aggregate purchase price of around $300 million (147 million pounds).

Gregory L Summe, chairman and chief executive of PerkinElmer, stated that ViaCell has a "strong, established market presence" and has built a high-growth business based on "innovative" umbilical cord blood preservation technology.

He added that PerkinElmer was "excited" by the opportunity to combine its existing pre- and neonatal screening services with those offered by ViaCell.

Robert F Friel, president and chief operating officer of PerkinElmer, commented: "A growing number of disorders – which today includes blood disorders, such as sickle cell anaemia, and metabolic disorders – are treatable using the cord blood stem cells gathered and preserved through ViaCell’s ViaCord offering."

Last month, PerkinElmer announced the expansion of its digital x-ray detector fabrication facility in Santa Clara, California.
ADNFCR-1050-ID-18306083-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.